Cargando…

Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots

The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosilkovska, M, Samer, C F, Déglon, J, Rebsamen, M, Staub, C, Dayer, P, Walder, B, Desmeules, J A, Daali, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151019/
https://www.ncbi.nlm.nih.gov/pubmed/24722393
http://dx.doi.org/10.1038/clpt.2014.83
_version_ 1782332986624049152
author Bosilkovska, M
Samer, C F
Déglon, J
Rebsamen, M
Staub, C
Dayer, P
Walder, B
Desmeules, J A
Daali, Y
author_facet Bosilkovska, M
Samer, C F
Déglon, J
Rebsamen, M
Staub, C
Dayer, P
Walder, B
Desmeules, J A
Daali, Y
author_sort Bosilkovska, M
collection PubMed
description The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), midazolam (CYP3A), and fexofenadine (P-gp) with coffee/Coke (CYP1A2) on four occasions. They received the cocktail alone (session 1), and with the CYP inhibitors fluvoxamine and voriconazole (session 2) and quinidine (session 3). In session 4, subjects received the cocktail after a 7-day pretreatment with the inducer rifampicin. The concentrations of probes/metabolites were determined in DBS and plasma using a single liquid chromatography–tandem mass spectrometry method. The pharmacokinetic profiles of the drugs were comparable in DBS and plasma. Important modulation of CYP and P-gp activities was observed in the presence of inhibitors and the inducer. Minimally invasive one- and three-point (at 2, 3, and 6 h) DBS-sampling methods were found to reliably reflect CYP and P-gp activities at each session.
format Online
Article
Text
id pubmed-4151019
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41510192014-09-04 Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots Bosilkovska, M Samer, C F Déglon, J Rebsamen, M Staub, C Dayer, P Walder, B Desmeules, J A Daali, Y Clin Pharmacol Ther Articles The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), midazolam (CYP3A), and fexofenadine (P-gp) with coffee/Coke (CYP1A2) on four occasions. They received the cocktail alone (session 1), and with the CYP inhibitors fluvoxamine and voriconazole (session 2) and quinidine (session 3). In session 4, subjects received the cocktail after a 7-day pretreatment with the inducer rifampicin. The concentrations of probes/metabolites were determined in DBS and plasma using a single liquid chromatography–tandem mass spectrometry method. The pharmacokinetic profiles of the drugs were comparable in DBS and plasma. Important modulation of CYP and P-gp activities was observed in the presence of inhibitors and the inducer. Minimally invasive one- and three-point (at 2, 3, and 6 h) DBS-sampling methods were found to reliably reflect CYP and P-gp activities at each session. Nature Publishing Group 2014-09 2014-05-07 /pmc/articles/PMC4151019/ /pubmed/24722393 http://dx.doi.org/10.1038/clpt.2014.83 Text en Copyright © 2014 American Society for Clinical Pharmacology and Therapeutics http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Articles
Bosilkovska, M
Samer, C F
Déglon, J
Rebsamen, M
Staub, C
Dayer, P
Walder, B
Desmeules, J A
Daali, Y
Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
title Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
title_full Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
title_fullStr Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
title_full_unstemmed Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
title_short Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
title_sort geneva cocktail for cytochrome p450 and p-glycoprotein activity assessment using dried blood spots
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151019/
https://www.ncbi.nlm.nih.gov/pubmed/24722393
http://dx.doi.org/10.1038/clpt.2014.83
work_keys_str_mv AT bosilkovskam genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT samercf genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT deglonj genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT rebsamenm genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT staubc genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT dayerp genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT walderb genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT desmeulesja genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots
AT daaliy genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots